Wall Street brokerages forecast that Kindred Healthcare, Inc. (NYSE:KND) will announce $1.77 billion in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Kindred Healthcare’s earnings, with the lowest sales estimate coming in at $1.76 billion and the highest estimate coming in at $1.78 billion. Kindred Healthcare posted sales of $1.79 billion during the same quarter last year, which indicates a negative year-over-year growth rate of 1.1%. The company is scheduled to issue its next quarterly earnings report on Monday, November 6th.

On average, analysts expect that Kindred Healthcare will report full year sales of $1.77 billion for the current year, with estimates ranging from $7.05 billion to $7.21 billion. For the next year, analysts forecast that the business will post sales of $6.21 billion per share, with estimates ranging from $6.08 billion to $6.35 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research analysts that follow Kindred Healthcare.

Kindred Healthcare (NYSE:KND) last released its earnings results on Thursday, August 3rd. The health services provider reported $0.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.16 by $0.03. Kindred Healthcare had a negative net margin of 16.31% and a positive return on equity of 3.49%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company posted $0.38 EPS. The business’s revenue was down 4.6% on a year-over-year basis.

KND has been the topic of several recent analyst reports. Zacks Investment Research downgraded shares of Kindred Healthcare from a “hold” rating to a “sell” rating in a research note on Thursday, July 6th. BidaskClub downgraded shares of Kindred Healthcare from a “buy” rating to a “hold” rating in a research note on Wednesday, July 12th. Barclays PLC reissued a “buy” rating and set a $13.00 price objective (up previously from $11.00) on shares of Kindred Healthcare in a research note on Sunday, May 7th. Deutsche Bank AG reduced their price objective on shares of Kindred Healthcare from $13.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, August 7th. Finally, Mizuho reissued a “neutral” rating and set a $9.00 price objective on shares of Kindred Healthcare in a research note on Monday, July 3rd. Four equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company. Kindred Healthcare currently has an average rating of “Hold” and an average price target of $9.94.

Shares of Kindred Healthcare (NYSE:KND) opened at 7.50 on Tuesday. Kindred Healthcare has a one year low of $5.65 and a one year high of $11.90. The stock’s 50 day moving average is $10.14 and its 200-day moving average is $9.23. The firm’s market cap is $652.64 million.

ILLEGAL ACTIVITY WARNING: “Kindred Healthcare, Inc. (KND) Expected to Announce Quarterly Sales of $1.77 Billion” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another publication, it was copied illegally and republished in violation of United States and international copyright & trademark laws. The original version of this story can be accessed at https://www.watchlistnews.com/kindred-healthcare-inc-knd-expected-to-announce-quarterly-sales-of-1-77-billion/1488373.html.

Several large investors have recently added to or reduced their stakes in the company. Amalgamated Bank raised its stake in Kindred Healthcare by 0.9% in the second quarter. Amalgamated Bank now owns 11,518 shares of the health services provider’s stock valued at $134,000 after buying an additional 108 shares during the last quarter. Louisiana State Employees Retirement System raised its stake in Kindred Healthcare by 0.6% in the second quarter. Louisiana State Employees Retirement System now owns 34,900 shares of the health services provider’s stock valued at $407,000 after buying an additional 200 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in Kindred Healthcare by 0.5% in the second quarter. PNC Financial Services Group Inc. now owns 48,725 shares of the health services provider’s stock valued at $568,000 after buying an additional 240 shares during the last quarter. Arizona State Retirement System raised its stake in Kindred Healthcare by 0.7% in the second quarter. Arizona State Retirement System now owns 44,664 shares of the health services provider’s stock valued at $520,000 after buying an additional 300 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Kindred Healthcare by 0.3% in the second quarter. Rhumbline Advisers now owns 178,931 shares of the health services provider’s stock valued at $2,085,000 after buying an additional 449 shares during the last quarter. 89.79% of the stock is owned by institutional investors.

Kindred Healthcare Company Profile

Kindred Healthcare, Inc is a healthcare services company. The Company, through its subsidiaries, operates transitional care (TC) hospitals, a home health, hospice and community care business, inpatient rehabilitation hospitals (IRFs), a contract rehabilitation services business, nursing centers and assisted living facilities across the United States.

Get a free copy of the Zacks research report on Kindred Healthcare (KND)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Kindred Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kindred Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.